The percentage of people being tested varied from 13% of the hypertension cohort for ACR or microalbumin testing, to 96% of the diabetes cohort having renal function or HbA1c tests (Supplementary Tables S6–S9). This evidence concerns the gene ACR and hypertensive disorder.